Amgen

Forecast & Rating34 analysts currently cover Amgen, with about 35.3% giving a positive rating — meaning they expect the stock to rise. The average price target is $395.67, about 11.5% downside from the current price of $447.28. Price targets range from $225.00 to $500.00 — a wide spread, showing clear disagreement over just how much Amgen can rise. Historically, about 92.3% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on Amgen's outlook. Data as of Oct 21, 2026; for reference only and not investment advice.